Abstract
It is well known that calorie restriction (CR) can retard the aging process in organisms ranging from yeast to non-human primates, and delay the onset of numerous age-related diseases including neurodegenerative disorders. Translation of the knowledge gained from CR research in animal models to disease prevention strategies in humans should provide therapeutic approaches for these diseases. Signaling pathways induced by CR are therefore potentially new therapeutic targets for neurodegenerative diseases. This review summarizes the evidence on key biological mechanisms underlying the beneficial effects of CR based on our current understanding, with particular emphasis on the recent impact of CR on neuroprotection, and on the emerging development of pharmacological agents that target signaling pathways induced by CR. We focus in particular on recent findings on sirtuins for prevention of neurodegenerative diseases.
Keywords: Calorie restriction, neurodegeneration, sirtuins, neurotrophin, PPAR, chaperone proteins, autophagy, Yeast, Non-human primates, Signaling pathways, Neuroprotection, Calorie restruction, PPARs, Biomarkers, Meal frequency, Glucose tolerance, Triiodothyronine, Alzheimer's disease, Parkinson's disease, Stroke, Substantia nigra, Cerebral occlusion, Huntington's disease, Amyotrophic lateral sclerosis, Calorie intake, Aging, C. elegans, Drosophila, Wallerian degeneration, p53, FOXO, PGC-1α, HSF1, Ku70, Calorie mimetics, NGF, BDNF, GDNF, Mitochondria, Antioxidant, Reservatrol, Multiple sclerosis, Rapamycin, CR mimetics
Current Drug Targets
Title: Potential Therapeutic Targets for Neurodegenerative Diseases: Lessons Learned from Calorie Restriction
Volume: 11 Issue: 10
Author(s): Wenzhen Duan and Christopher A. Ross
Affiliation:
Keywords: Calorie restriction, neurodegeneration, sirtuins, neurotrophin, PPAR, chaperone proteins, autophagy, Yeast, Non-human primates, Signaling pathways, Neuroprotection, Calorie restruction, PPARs, Biomarkers, Meal frequency, Glucose tolerance, Triiodothyronine, Alzheimer's disease, Parkinson's disease, Stroke, Substantia nigra, Cerebral occlusion, Huntington's disease, Amyotrophic lateral sclerosis, Calorie intake, Aging, C. elegans, Drosophila, Wallerian degeneration, p53, FOXO, PGC-1α, HSF1, Ku70, Calorie mimetics, NGF, BDNF, GDNF, Mitochondria, Antioxidant, Reservatrol, Multiple sclerosis, Rapamycin, CR mimetics
Abstract: It is well known that calorie restriction (CR) can retard the aging process in organisms ranging from yeast to non-human primates, and delay the onset of numerous age-related diseases including neurodegenerative disorders. Translation of the knowledge gained from CR research in animal models to disease prevention strategies in humans should provide therapeutic approaches for these diseases. Signaling pathways induced by CR are therefore potentially new therapeutic targets for neurodegenerative diseases. This review summarizes the evidence on key biological mechanisms underlying the beneficial effects of CR based on our current understanding, with particular emphasis on the recent impact of CR on neuroprotection, and on the emerging development of pharmacological agents that target signaling pathways induced by CR. We focus in particular on recent findings on sirtuins for prevention of neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Duan Wenzhen and A. Ross Christopher, Potential Therapeutic Targets for Neurodegenerative Diseases: Lessons Learned from Calorie Restriction, Current Drug Targets 2010; 11 (10) . https://dx.doi.org/10.2174/1389450111007011281
DOI https://dx.doi.org/10.2174/1389450111007011281 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and Strategies
Current Pharmaceutical Design Editorial (Mini Hot-Topic: Determination of the Antioxidant Capacity of Dietary Substances and Extracts from Natural Sources at Molecular, Cellular And Whole Tissue Level: Sensors and Complex Microfluidic Structures)
Current Analytical Chemistry Increased CRMP2 Phosphorylation is Observed in Alzheimers Disease; Does this Tell us Anything About Disease Development?
Current Alzheimer Research The Impact of Mitochondrial DNA and Nuclear Genes Related to Mitochondrial Functioning on the Risk of Parkinson’s Disease
Current Genomics The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model
CNS & Neurological Disorders - Drug Targets Alzheimers Disease and Immunotherapy
Current Alzheimer Research Multitarget Network Strategies to Influence Memory and Forgetting: The Ras/Mapk Pathway as a Novel Option
Mini-Reviews in Medicinal Chemistry Regulatory Roles of the Ubiquitin-Proteasome System in Cardiomyocyte Apoptosis
Current Molecular Medicine Cytokines in Neuroinflammation and Alzheimers Disease
Current Drug Targets Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Intrinsically Disordered Proteins: A Focused Look at Fuzzy Subjects (Guest Editor: Vladimir N. Uversky)]
Current Protein & Peptide Science Serotonergic System and Its Role in Epilepsy and Neuropathic Pain Treatment: A Review Based on Receptor Ligands
Current Pharmaceutical Design Medicinal Plants in Neurodegenerative Diseases: Perspective of Traditional Persian Medicine
Current Drug Metabolism A MicroRNA-BDNF Negative Feedback Signaling Loop in Brain: Implications for Alzheimer’s Disease
MicroRNA Meet Our Editorial Board Member:
Current Alzheimer Research Synthesis and Neuroprotective Biological Evaluation of Quinazolinone Derivatives via Scaffold Hopping
Current Organic Synthesis Hydroximic Acid Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness
Current Pharmaceutical Design Mitochondrial Neuroprotection in Traumatic Brain Injury: Rationale and Therapeutic Strategies
CNS & Neurological Disorders - Drug Targets Structure and Function Relationship in Prolyl Oligopeptidase
CNS & Neurological Disorders - Drug Targets